Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05010096 |
Title | BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid Tumors |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | M.D. Anderson Cancer Center |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries |